Search
for

    Sort by

    Research 31–60 of 1000+

    1. Minoxidil for patchy alopecia areata: systematic review and meta‐analysis Journal of The European Academy of Dermatology and Venereology · 2019 · 20 citations
    2. Combined Effect of Microneedling and Platelet-Rich Plasma for the Treatment of Acne Scars: A Meta-Analysis Frontiers in Medicine · 2022 · 7 citations
    3. ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW International Journal of Innovative Technologies in Social Science · 2025
    4. Deoxycholic acid in the submental fat reduction: A review of properties, adverse effects, and complications Journal of cosmetic dermatology · 2020 · 25 citations
    5. Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients. PubMed · 2025
    6. Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients Acta Dermatovenerologica Alpina Pannonica et Adriatica · 2025
    7. Baricitinib as the first systemic treatment for severe alopecia areata Expert Review of Clinical Immunology · 2023 · 2 citations
    8. Efficacy of oral tofacitinib in moderate to severe alopecia areata, totalis and universalis at the tertiary care hospital, Karachi Journal of the Pakistan Medical Association · 2025
    9. Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results Journal of the European Academy of Dermatology and Venereology · 2025
    10. Fluoroquinolone-induced serious, persistent, multisymptom adverse effects Case Reports · 2015 · 39 citations
    11. Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study Dermatology and Therapy · 2026
    12. Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis Frontiers in pharmacology · 2024
    13. Real-World Systemic Treatment Patterns and Outcomes of Children With Severe Alopecia Areata: A French Nationwide Study (ESTAPED Cohort) Pediatric Drugs · 2026
    14. Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study Journal of the European Academy of Dermatology and Venereology · 2024
    15. Safety and Efficacy of Mesotherapy with Placenta Polypeptide Injection for Moderate-to-Severe Sensitive Skin: A Multicenter, Randomized, Controlled Trial Clinical Cosmetic and Investigational Dermatology · 2026
    16. Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data Dermatology and Therapy · 2023
    17. Effectiveness and Safety of Resilient Hyaluronic Acid (RHA) Dermal Fillers for the Correction of Moderate-to-Severe Nasolabial Folds in People of Color: Post Hoc Subgroup Analyses of US Pivotal Clinical Data Aesthetic Surgery Journal · 2023 · 2 citations
    18. P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis Poster presentations · 2024
    19. Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population Dermatologic Therapy · 2022 · 2 citations
    20. Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis Journal of The American Academy of Dermatology · 2016
    21. Cutaneous toxicities of new treatments for melanoma Clinical & Translational Oncology · 2018 · 25 citations
    22. Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution Cancers · 2024 · 3 citations
    23. Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment Supportive Care in Cancer · 2013 · 52 citations
    24. Tapinarof cream for atopic dermatitis: Pharmacokinetics, systemic exposure, and preliminary efficacy/safety results Journal of The American Academy of Dermatology · 2017
    25. Cutaneous manifestations associated with immune checkpoint inhibitors Frontiers in immunology · 2023 · 14 citations
    26. 420 Severe thiopurine-induced myelotoxicity and hair loss in Japanese patients with NUDT15 gene variant: A retrospective case-control study Journal of Investigative Dermatology · 2018
    27. Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology Anais Brasileiros de Dermatologia · 2020 · 22 citations
    28. Adverse effect profile with low-dose methotrexate therapy in patients suffering with rheumatic diseases National journal of physiology, pharmacy and pharmacology · 2023
    29. Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up Journal of asthma and allergy · 2024
    30. Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study American Journal of Clinical Dermatology · 2026 · 1 citations